GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several ...

The findings from two clinical trials suggest that a lower dose of GLP-1 drugs, or switching to an oral pill like Foundayo, can help to maintain weight loss.

The IPC has called for close monitoring of adverse reactions to semaglutide and other GLP-1 medications amid rising usage.

Two of the most common bariatric procedures are gastric sleeve surgery and gastric bypass.

Three out of four adults who begin taking a GLP-1 medication stop using it within a year.

It seems like everyone, including public employees, are jumping on the GLP-1 bandwagon. Just as quickly, some of their health ...

The evidence is also strong that these medications decrease the risk of heart disease -- both in people with and without ...

My brother-in-law is a lovely man, but for years, he's suffered from obesity. He also gambles and drinks alcohol too much. I ...

With obesity affecting almost 2 billion adults worldwide, the recent introduction of GLP-1 agonists into the consumer market ...

A review published in BMC Ophthalmology has found that GLP-1 receptor agonists may help protect against ocular hypertension, glaucoma, late-stage diabetic retinopathy, and dry age-related ...

The crackdown comes amid booming global demand for GLP-1 therapies — a class of drugs that mimic a natural hormone in the ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.